The group of Professor Jürg Gertsch (www.gertschgroup.com) at the University of Bern, Switzerland (www.unibe.ch), Institute of Biochemistry and Molecular Medicine (www.ibmm.unibe.ch/) investigates the role of the endocannabinoid system (ECS) for neuropsychiatric and inflammatory conditions with a strong interest in drug discovery. We have collaborations with other research groups worldwide. Currently there are several openings.